Cite
HARVARD Citation
Abdallah, A. et al. (2023). Clinical efficacy of retreatment of daratumumab‐based therapy (D2) in daratumumab‐refractory multiple myeloma. European journal of haematology. pp. 626-632. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Abdallah, A. et al. (2023). Clinical efficacy of retreatment of daratumumab‐based therapy (D2) in daratumumab‐refractory multiple myeloma. European journal of haematology. pp. 626-632. [Online].